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Expression of a Leukocyte-Specific Antigen During
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Laboratory of Developmental Immunology, Department ofAnatomy, University ofNebraska Medical Center, Omaha, NE 68198-6395
The monoclonal antibody CL21 recognizes a determinant present on the surface of
leukocytes, but not on erythrocytes or nonhemopoietic tissue. The CL21 antigen was
first expressed at 48 hr of development at 20C (stage 28) on embryonic cells cultured
from lateral plate mesoderm. Based on immunofluorescence staining and flow
cytometric analysis, the distribution of fluorescence intensity of larval thymocytes and
splenocytes was unimodal. Distributions of dull and bright cells were detected in both
adult thymocytes and splenocytes. These different subpopulations appeared during the
late perimetamorphic period. Adult splenocytes were metabolically activated when
cultured in the presence of mAb CL21 bound to a substrate but not in the presence of
mAb CL21 in suspension. Immunoprecipitation and SDS-PAGE under nonreducing
conditions revealed that a single 180-kD molecule was expressed on thymocytes.
Analysis of splenocytes demonstrated the presence of two molecules having similar
molecular mass that resolved to a single band under reducing conditions.
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INTRODUCTION
The Xenopus embryo is a unique model for study-
ing early development of the hematopoietic and
immune systems. Extensive study has shown that
many aspects of the Xenopus hematopoietic and
immune systems are similar to those of more
recent vertebrates (Du Pasquier et al., 1989).
Additionally, Xenopus embryos are accessible to
experimental intervention at all developmental
stages, making in vivo, physiological studies of
the earliest events in hematopoietic differen-
tiation possible.
In order to examine the parameters involved in
stem-cell development in more detail, we have
removed lateral plate mesoderm from stage 20
Xenopus embryos and placed it in culture
(Turpen and Smith, 1985). Under these con-
ditions, morphologically recognizable hemato-
poietic cells, primarily erythrocytes,
monocytes/macrophages, and neutrophils differ-
entiate after 5 days. However, a major limitation
of these studies has been the use of morphologi-
cal differentiation as an end point of the assay.
*Corresponding author.
Thus, we have been unable to examine the earl-
iest events of hematopoiesis and have been
unable to determine the time in development
when lateral plate mesoderm begins to express
the hematopoietic phenotype.
In this paper, we report on the development of
a monoclonal antibody, CL21, which detects a
180-kD antigen expressed on the cell surface of
leukocytes. The CL21 antigen is initially detected
early in development, at stage 28 (approximately
48 hr postfertilization), and is stably expressed
throughout the larval period. Experiments car-
ried out using adult splenocytes show that bind-
ing of the CL21 determinant increases metabolic
activity and suggests that CL21 may participate
in either cell-cell or cell-extracellular matrix
interactions.
RESULTS
Cell and Tissue Distribution
Flow cytometric analyses of cell suspensions
from larval, perimetamorphic, and adult thymus,
spleen and peripheral blood, stained with either






and 10% were dull. Only the intermediate sub-
population was detectable prior to the com-
pletion of metamorphosis. Larval splenocytes
exhibited a unimodal distribution in fluorescene
intensity. A bimodal distribution was observed
in the adult; 65% of positive splenocytes were
stained brightly. These subpopulations became
detectable near the completion of metamor-
phosis. Although we were able to discriminate
two splenocyte and three thymocyte subpopu-
lations in all frogs examined (n=5), the pro-
portion of dull and bright cells varied with each
individual. Five percent of cells in larval periph-
eral blood stained with the antibody. The percent
of positive cells in adult peripheral blood
decreased to 2%. The proportion of peripheral
blood cells positive for mAb CL21 corresponded
to WBC counts in peripheral blood of larvae and
li
adults. There was no staining of either larval or
adult preparations with an isotype control anti-
body specific for swine cytotoxic T-cells (mAb
yr 76-2-11).
In order to determine the identity of the cells
negative for mAb CL21, adult splenocytes were
stained and sorted into CL21 positive and CL21
b 6o o negative populations. Resulting suspensions
were cytospun and examined for morphology
FIGURE Flow cytometric analysis of CL21 expression.
Thymus, spleen, and peripheral blood populations were
analyzed for CL21 expression at 35 days (stage 55), 63 days
(stages 65-66), and year postfertilization. Dotted lines
represent fluorescence intensity after staining with an isotype
control antibody and solid lines represent fluorescence
intensity after staining with mAb CL21. 3x104 cells were
analyzed from each population.
mAb CL21 or isotype control mAb 76-2-11
(IgG2ak) are shown in Fig. 1. All hematopoietic
cells in the thymus stained with mAb CL21. Lar-
val thymocytes from 20-, 35- and 42-day-old ani-
mals showed a unimodal distribution of fluor-
escence intensity, but adult thymocytes exhibited
a tripartite distribution. The majority (70%) of
thymocytes displayed an intermediate fluor-
escence intensity, while 20% were more intense
(Fig. 2). Thrombocytes were identified using the
periodic acid-schiff reaction [PAS] (Hadji-Azimi
et al., 1987; Hayhoe and Quagline, 1988). Panel
2A shows the fluorescence profile of unsorted
splencocytes. Erythrocytes, leukocytes (2D), and
PAS positive thrombocytes (2G and H) were
identified in this population. CL21 positive cells
(2B) were identified morphologically as leuko-
cytes and did not contain PAS positive cells (2E).
On the other hand, CL21 negative splenocytes
(2C) were identified as erythrocytes (2F) and PAS
positive thrombocytes (panels 21 and 2J). Thus,
the CL21 negative cells seen in the spleen and
peripheral blood (Fig. 1) include mature erythro-
cytes and thrombocytes. The remaining leuko-
cytes are CL21 positive.
Tissue distribution of CL21 in adult frogs was
determined by staining frozen sections with
FIGURE 2 Erythrocytes and thrombocytes are CL21 negative. Adult splenocytes were sorted into CL21 positive and CL21
negative populations on the basis of fluorescence intensity. Each cell population was characterized by morphology and
cytochemistry (PAS reaction). Panels A, B, and C represent fluorescence profiles of unsorted, CL21 /, and CL21- splenocytes,
respectively. Panels D, E, and F represent Giemsa stained cytospins from unsorted, CL21 /, and CL21- splenocytes, respectively.
Panels G and are phase-contrast photomicrographs, and panels H and are bright field photomicrographs of cytospins after the
PAS reaction. Matching arrows identify PAS thrombocytes in identical fields from unsorted (G, H) and CL21- (I, J) preparations.
Bar=10 microns.LEUKOCYTE ONTOGENY IN XENOPUS 297
FIGURE 2298 P.B. SMITH AND J.B. TURPEN
mAbs CL21 and AM20 (data not shown). The
thymic cortex stained brighter than the medulla.
There were focal accumulations of positive cells
in the perihepatic layer of the liver. Additionally,
mAb CL21 stained isolated cells within the der-
mal layer of the skin. The CL21 antigen was not
expressed in heart muscle, gut epithelium, or
kidney parenchyma. This distribution of the
CL21 antigen coincided with the distribution of
MHC II determinants recognized by mAb AM20,
except that AM20 also stained isolated cells in the
kidney parenchyma and gut epithelium.
Molecular Weight Characterization
Surface proteins were radiolabeled with 125I and
the antigen recognized by mAb CL21 was immu-
noprecipitated from lysates of adult thymus and
spleen. Figure 3 shows the results after separ-
ation on polyacrylamide gels under reducing and
nonreducing conditions. Under nonreducing con-
ditions, the CL21 antigen from the thymus (lane
a) migrated as a single band with a relative Mr
between 160 and 180 kD. The CL21 antigen im-
munoprecipitated from splenic lysates (lane b)
was represented by two distinct bands within the
same molecular-weight range. (However, the
molecular weight of the upper band may not be
accurate because the radioactive band appears to
be distorted by the unlabeled IgG.) Under reduc-
ing conditions, a major and a diffuse band were
evident in precipitates from the thymus (lane c),
but splenic (lane d) antigens migrated as a single
band. When the CL21 determinant was immuno-
precipitated from 20-, 35-, and 42-day-old larval
thymuses and spleens, no age-related differences
in electrophoretic mobility were observed (data
not shown).
Figure 4 shows the results of an experiment to
confirm that the antigen recognized by mAb
CL21 was absent from erythrocytes. Adult per-
ipheral blood was fractionated over a ficoll gradi-
ent to remove the majority of leukocytes. Cell
suspensions of thymus, spleen, and purified
erythrocytes were radiolabeled with 125I, immun-
oprecipitated using mAb CL21, and analyzed
under reducing conditions. The presence of the
160-180-kD doublet was confirmed in the thy-
mus (lane a) and as well the single 180-kD band
in the spleen (lane b). No evidence of a surface
molecule recognized by mAb CL21 was detected
in erythrocyte lysates (lane c).
a b c
a b c d
FIGURE 3 Molecular-weight characterization of CL21
determinant. Immunoprecipitates from radiolabeled adult
thymus (lanes a and c) and spleen (lanes b and d) were
analyzed by SDS-PAGE under nonreducing (lanes a and b) and
reducing (lanes c and d) conditions. Positions of 200 and 100-
kD molecular-weight markers are indicated by arrows.
FIGURE 4 CL21 is not expressed on erythrocytes.
Immunoprecipitates from radiolabeled thymus (lane a), spleen
(lane b), and ficoll purified peripheral blood erythrocytes (lane
c) were analyzed by SDS-PAGE under reducing conditions.
Arrows indicate position of 200 and 100-kD molecular-weight
markers.LEUKOCYTE ONTOGENY IN XENOPUS 299
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FIGURE 5 The determinant
recognized by mAb CL21 is a subset
of the determinants recognized by
mAb XL-1. Radiolabeled adult
thymocytes (T) and splenocytes (S)
were precleared with either XL-1
(lanes b, c, h, and i) or CL21 (lanes e,
f, k, and 1). Lanes a, b, e, g, h, and k
were immunoprecipitated with
mAb XL-1. Lanes c, d, f, i, j, and
were immunoprecipitated with
CL21. Arrows indicate position of
200, 100, and 69-kD molecular-
weight markers analyzed under
reducing conditions.
Recently, Ohinata et al. (1989) have reported
the development of mAb XL-1, which recognized
determinants present on Xenopus leukocytes but
not erythrocytes. Western blot analysis of the XL-
1 determinants revealed several molecules rang-
ing from 180-250 kD in thymocytes and spleno-
cytes, but none in erythrocytes. In contrast to
CL21, XL-1 reacted with thrombocytes as well as
leukocytes. In addition, mAb XL-1 reacted with
serum components (35-200 kD). Therefore, it was
important to establish whether mAbs CL21 and
XL-1 recognize the same determinant. Figure 5
shows the results of an experiment in which thy-
mocytes and splenocytes were radiolabeled with
125I and surface molecules were analyzed using
these two antibodies. Immunoprecipitations from
thymus and spleen using mAb XL-1 are shown in
lanes a and g. Under these conditions, this anti-
body recognized a family of cell-surface determi-
nants ranging from 200 to 65 kD. Lanes b and h
show the results when thymic and splenic lysates
were first precleared with mAb XL-1 followed by
immunoprecipitation with mAb XL-1. These data
demonstrate that all molecules recognized by the
mAb XL-1 were removed by preclearing. Lanes c
and show the results when lysates were pre-
cleared with mAb XL-1 and immunoprecipitated
with mAb CL21. Note that preclearing with mAb
XL-i removed all activity precipitable with mAb
CL21. The complementary experiment is shown
in lanes d, e, f for thymus and j, k, for spleens,
respectively. Lane d is an immunoprecipitation
from the thymus using mAb CL21. Lane e rep-
resents thymic lysate that was precleared with
mAb CL21 and immunoprecipitated using mAb
XL-1. Note that the 180-kD band present in lane a
is absent from lane e. Lane f represents both pre-
clearing and immunoprecipitation with mAb
CL21. Similar results were seen with the spleen.
Therefore, the molecule(s) recognized by mAb
CL21 belongs to a family of molecules recognized
by mAb XL-1.
Splenocyte Activation in the Presence of
mAb CL21
We wished to determine what effect, if any, mAb
CL21 had on splenocyte activation as colormetri-
cally detected using reduction of the tetrazolium
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FIGURE 6 Metabolic activation of adult splenocytes by mAb CL21 bound to a substrate. (A) Dose response to affinity-purified
CL21 or isotype control (IgG). (C) Dose respose to CL21 or XT-2.1 ascites. (B and D) Augmentation of Con-A response (0, 0.1, 1,
and 10 Mg/ml) in the presence of CL21, either affinity-purified (20 Mg/ml) or ascites (10-*dilution). Each point represents mean+
s.e. of three replicates. r Indicates points of statistical difference (p<0.05) using Student’s test for small samples. Graphs are
representative of five separate experiments.
detects live, metabolically active cells, is useful
for measuring cytoxicity, proliferation, or acti-
vation since the degree of signal generated
depends on the degree of cellular metabolic
activity (Mossman, 1983). Adult splenocytes
were cultured in the presence of different concen-
trations of mAb CL21 attached to 96 well flat bot-
tom plates via goat antimouse IgG. As can be
seen in Fig. 6A and 6C, a dose-dependent meta-
bolic activation was observed in the presence of
either affinity-purified mAb CL21 or mAb CL21
ascites, but not in the presence of affinity-puri-
fied mAb 76-2-11 or mAb XT2.1 ascites. It should
be noted that metabolic activation by mAb CL21
did not lead to a detectable increase in DNA syn-
thesis as measured by 3H-thymidine incorpor-
ation (data not shown). Figures 6B and 6D show
the effect of immobilized mAb CL21 on the
splenocyte response to the T-cell mitogen Con-A.
An enhancement of the Con-A response was seen
in the presence of mAb CL21, but not in the pres-
ence of mAbs 76-2-11 or XT2.1. When these anti-
bodies (CL21, XT2.1, 76-2-11 or goat antimouse
IgG) were used in suspension, these specific
FIGURE 7 Developmental expression of CL21 determinant on hematopoietic precursors. Phase contrast (A, C, E) and
fluorescence (B, D, F) photomicrographs of cells from cultures of lateral plate mesoderm. A-D were from 1.5-day-old cultures
(control embryos at stage 27/28) and E and F were from 2-day-old cultures (control embryos at stage 35). B was stained with
isotype control antibody and D and F were stained with mAb CL21. Bar=10 microns; arrows show same cell in each field.LEUKOCYTE ONTOGENY IN XENOPUS 301
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dose-dependent
(data not shown).
responses were not observed
Developmental Expression of the Antigen
Recognized by mAb CL21
Finally, we wanted to determine the time during
ontogeny when CL21 antigen expression begins.
Representative blastulae, gastrulae, neurlae, and
tailbud embryos (stages 8, 11, 14, 19, and 23;
Nieuwkoop and Faber, 1967) were dissociated in
Ca++- and Mg//-free Steinberg’s solution and
stained with eit.her mAb CL21, AM20, 6.16, or
XT2.1. We did not detect expression of CL21 nor
any other determinant at these early stages (data
not shown).
At stage 19 (late neurulae), lateral plate meso-
derm was removed from embryos and placed in
culture for periods ranging from 1 to 10 days.
Stage-matched control embryos were reared
under the same time and temperature conditions
as the cultures. At selected intervals, cultures
were harvested and stained with either mAb
CL21, XT2.1, 6.16, or AM20. Since mAb AM20 is
the same isotype as CL21, this reagent also
served as an isotype control. At no time during
this experiment was staining with mAb XT2.1,
6.16, or AM20 detectable (Fig. 7A and 7B). CL21
expression was first detected in the perinuclear
region of an isolated cell after 1.5 days in culture.
Control embryos had reached stage 27/28 (3 hr
after the beginning of muscular response) (Fig.
7C and D). At this stage, morphologically reco-
gnizable hematopoietic cells have not differen-
tiated in culture and all cells are characterized by
prominant yolk granules. After 2 days in culture,
control embryos had reached stage 35 (hatching)
and. the number of CL21-expressing cells
increased in both frequency and intensity (Figs.
7E and F). At this stage, morphological differen-
tiation was still absent. Beginning at 2.5 days of
culture, stage 37 for control embryos, cells
expressing the CL21 antigen were widespread
(Figs. 8A and B). During the following 4 days,
control embryos reached stage 46 (feeding) and
CL21-expressing leukocytes could be readily dis-
tinguished from non-CL21-expressing erythro-
cytes (arrows, Figs. 8C and D). Previous studies
correlated benzidine positive erythroid cells with
heterochromatic nuclear morphology and central
nuclear location (Turpen and Smith, 1985). Thus,
the antigen recognized by mAb CL21 is
expressed by differentiating hematopoietic cells
early in embryonic development prior to overt,
morphological differentiation.
DISCUSSION
The mAb CL21 recognizes a 160-180-kD mol-
ecule expressed on the surface of Xenopus leuko-
cytes, but not on erythrocytes or somatic tissue.
The antigen was not detected in embryonic tis-
sues prior to 48 hr of development. Beginning at
48 hr, the antigen was expressed on differen-
tiating lateral plate mesoderm, the embryonic tis-
sue that gives rise to hematopoietic precursors.
Functional studies have shown that binding of
the antigen recognized by mAb CL21 increased
metabolic activity of adult splenocytes and
enhanced the splenocyte response to Con-A.
Based on molecular weight and tissue distri-
bution, we hypothesize that the CL21 determi-
nant may be similar to members of the leukocyte
common antigen family (CD45) described in mice
and humans (Thomas, 1989).
Members of the CD45 family make up approxi-
mately 10% of the molecules on the lymphocyte
surface and contain much of the carbohydrate
moieties expressed by lymphoid cells (Tonks et
al., 1989). Lymphocyte subpopulations can be
delineated on the basis of distinct CD45 isoforms
recognized by different monoclonal antibodies
(Smith et al., 1986). Moreover, during maturation
of prothymocytes to mature T cells, there is
developmentally regulated expression of CD45
family members (Lefrancois and Goodman,
1987). For these reasons, we wanted to compare
the antigens recognized by mAb CL21 with the
putative leukocyte common antigen recognized
by mAb XL-1 (Ohinata et al., 1989). It was
thought that the antibodies might detect different
isoforms within a CD45-1ike family and could
therefore be useful for defining subsets of
hematopoietic cells. However, our experiments
suggest that the XL-1 antibody indiscriminately
recognized determinants present on several cell-
surface molecules. This pattern of reactivity sug-
gests that mAb XL-1 may be directed against
common carbohydrate epitopes. On the other
hand, mAb CL21 recognized a unique subset of
the antigens detected by mAb XL-1.
Under nonreducing conditions, mAb CL21 pre-
cipitated two bands from splenocytes and oneLEUKOCYTE ONTOGENY IN XENOPUS 303
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FIGURE 8 Developmental expression of CL21 (continued). Phase contrast (A and C) and mAb CL21 fluorescence staining (B and
D) of cells from cultures of lateral plate mesoderm established for 2.5 days (A and B) and 7 days (C and D). Control embryos were
at stages 37 and 46, respectively. Arrows in C and D indicate erythrocytes. Bar=10 microns.
major band from adult thymocytes. Under reduc-
ing conditions, the multiple splenocyte bands
resolved into a single band, and an additional
diffuse band appeared in thymocytes. These data
suggest that Xenopus leukocyte subpopulations
express similar high-molecular-weight molecules
that may exhibit differences in tertiary structure
when in their native, nonreduced configuration.
By using flow cytometric analysis, three sub-
populations in the adult thymus could be dis-
tinguished on the basis of fluorescence intensity
following staining with mAb CL21. In sections of
the adult thymus, the cortex stained brighter
than the medulla. However, during larval devel-
opment, there appeared to be a single population
of brightly staining cells. Whether fluorescence
intensity will be useful for discriminating matu-
ration sequences within Xenopus thymocyte sub-
populations remains to be determined.
Depending on conditions, antibodies to CD45
have been shown to either augment or inhibit T-
cell proliferation (Pingel and Thomas, 1989;
Thomas, 1989; Samelson et al., 1990). Ledbetter et
al. (1988) reported that CD45 regulates both sig-
nal transduction by lymphocyte-receptor mol-
ecules as well as T- and B-cell proliferation. Lym-
phocyte activation, defined as an increase in
cytoplasmic-free calcium, occurs when either304 P.B. SMITH AND J.B. TURPEN
CD2 or CD3 are cross-linked on the cell surface.
This activation was inhibited when antibodies to
CD45 were cross-linked With antibodies to CD3.
On the other hand, lymphocyte activation
induced by cross-linking CD4 was amplified
when CD4 was cross-linked to CD45. Thus, CD45
can either up regulate or down regulate signal
transduction, depending upon the cell-surface
receptor with which it becomes associated. Since
CD45 has been shown to be a receptor protein
tyrosine phosphotase (PTPase) (Tonks, et al.,
1988), these different metabolic affects may
reflect cifferent intracellular substrates for
PTPase associated with CD2, CD3, or CD4. In the
present experiments, we examined the effect of
mAb CL21 binding on splenocyte activation.
When mAb CL21 was immobilized on a sub
strate, a dose-dependent splenocyte activation
could be detected, albeit the magnitude of this
activation was small. In the presence of Con-A,
immobilized mAb CL21 augmented the spleno-
cyte mitogen response. Although the enhance-
ment of the Con-A response suggests that CL21
may be involved in T-cell activation, the aug-
mentation we observed could also be due to
recruitment of an additional population of cells
that did not respond to the mitogen. Thus, the
conditions of the present experiments did not
address the specific cell type that is responsive to
mAb CL21..
Neither splenocyte activation nor enhancement
of the Con-A response was observed when mAb
CL21 was present in suspension. The require-
ment that mAb CL21 must be bound to a sub-
strate in order to effect activation is consistent
with the notion that the natural ligand may be
either on the surface of other cells or a compon-
ent of the extracellular matrix.
The molecular mechanisms involved in lineage
specification within the hematopoietic system are
not known. Recent experiments using human
bone marrow indicate that the 180-kD isoform of
the CD45 antigen (CD45RO) is expressed on
more primitive, clonogenic hematopoietic pro-
genitors, including the primitive erythroid pro-
genitors BFU-e and precursors able to initiate
long-term bone marrow cultures (Lansdorp et al.,
1990). In contrast, most CFU-gm express the 220-
kD isoform, CD45R. In Xenopus, mRNA for the ]/
chain of larval hemoglobin (ffF1) is detectable
between stages 28 and 32 (Banville and Williams,
1985), the same period when CL21 expression is
first detected. Because of its early developmental
expression, the 180-kD CL21 antigen may be one
of the first molecules transcribed following com-
mittment of unrestricted lateral plate mesoderm
to hematopoiesis and is most likely present on
pluripotential hematopoietic stem cells. This
observation invites speculation that the CL21
determinant may be an accessory component of
signal transduction complex involved in specify-
ing cell lineage within the hematopoietic system.
By analogy with CD45 and T-cell signal transduc-
tion, CL21 may modulate signals originating
from an array of receptors present on the surface
of primitive hematopoietic precursors.
MATERIALS AND METHODS
Animals
Gravid female Xenopus were initially obtained
from commercial suppliers (Xenopus I, Ann
Arbor, MI; Carolina Biological Supply, Bur-
lington, NC) and have been repeatedly bred in
the laboratory. All animals used in these studies
were derived from outbred embryos fertilized in
the laboratory and reared under optimal con-
ditions. Postmetamorphic juveniles were at least
6 months of age.
Preparation of Monoclonal Antibodies
Immunogens. Peripheral blood and thymuses
were removed from juvenile frogs, washed, and
stored at 4C over night in amphibian phosphate-
buffered saline (APBS) containing 0.5% BSA.
Plasma membranes were prepared according to
the dextranpolyethylene glycol aqueous two-
phase system of Brunette and Till (1971). Briefly,
50 g of 20% dextran (w/w); 25.75 g of 30% PEG
(w/w); 24.75ml distilled water; 83.25ml of
0.22 M phosphate buffer, pH 6.5; and 20 ml of
10-2M ZnCI2 were mixed in a separatory funnel
and allowed to separate at 4C. Cell suspensions
were washed once in APBS, suspended in 10-3M
ZnCI2, and incubated 30 min at 4C. Cells were
gently ruptured on ice using a 7ml Dounce
homogenizer with pestel A (800-1000 strokes).
The resulting homogenate was pelleted (10,000 X
G) and suspended in 1.5 ml of the top phase of
the separating system. 1.5 ml of the bottom phase
was added, the phases were mixed and centri-LEUKOCYTE ONTOGENY IN XENOPUS 305
fuged at 10,000xG for 10min in a fixed-angle
rotor using an IEC model B200 high-speed centri-
fuge. The plasma membranes, confirmed by elec-
tron microscopy of erythrocyte preparations
(data not shown), were concentrated at the
interface between the two phases and the nuclei
were found in the pellet. The interface was col-
lected, diluted fourfold with distilled water, and
the membranes were pelleted by an additional
centrifugation at 10,000xG for 10 min. The final
membrane pellet was suspended in mammalian
saline.
Immunization. In order to tolerize mice to
Xenopus erythrocyte cell-surface determinants, 3-
month-old Balb/c mice were injected subcutane-
ously with purified membranes from 108 erythro-
cytes emulsified in complete Freund’s adjuvant
(CFA). Three days following the immunization,
mice were injected with 150mg/kg cyclophos-
phamide, delivered in three equal doses at 2-day
intervals (Matthew and Patterson, 1983). One
week after the last injection, mice were subcut-
aneously immunized with membranes from 5x
107 thymocytes emulsified in CFA. Mice were
boosted at biweekly intervals for 2 months with
thymocyte membranes emulsified in incomplete
Freund’s adjuvant. Three days prior to fusion,
mice were injected intraperioteneally with thym-
ocyte membranes suspended in PBS.
Fusion. Draining lymph nodes were fused
with NS1 plasmocytomas using standard proto-
cols. Fusion, initial culturing of hybridomas, and
cloning by limiting dilution were done in the
University of Nebraska Medical Center Mono-
clonal Antibody Facility.
Screening. Hybridomas were screened by
flow cytometry beginning at 10 days postfusion.
Mixtures containing 105 thymocytes and 105
erythrocytes were incubated in hybridoma super-
natant diluted to amphibian osmolarity, washed
two times, incubated in FITC labeled goat anti-
mouse Ig, and analyzed for green fluorescence
using an Ortho 50 H flow cytometer. The eliptical
shape of frog erythrocytes enabled us to estab-
lished gates such that one region contained pre-
dominantely thymocytes with a 15% RBC con-
tamination and a second region contained mostly
erythrocytes. The initial screening was based on
the presence of a positive signal in the thymocyte
window coupled with the absence of signal in the
erythrocyte window. Selected wells were cloned
three times by limiting dilution. The selected
hybridoma, CL21, secretes an IgG2ak antibody.
Immunoprecipitation
Cell-surface radiolabeling of Xenopus hemato-
poietic cells with 125I followed by immunoprecip-
itation and protein analysis were carried out
according to published methods (Flajnik et al.,
1984; Kauffman et al., 1985). Briefly, surface mol-
ecules were labeled using lactoperoxidase catal-
ized iodination. Labeled cells were lysed in
0.5ml buffer consisting of 20mM Tris-HC1,
0.15 M NaC1, 1 mM MgC12, and 2% NP-40. For
each immunoprecipitation, 106 cell equivalents
were precleared three times with 15 tl of a 50%
suspension of Protein A-sepharose, incubated
overnight with the ascites from either CL21 or
XL-1 and precipitated with Protein A-sepharose.
Sepharose beads were washed three times in pro-
tein-A wash buffer (50mM Tris-HC1, pH 8.0;
5 mM EDTA; 650mM NaC1; 0.5% Triton-X-100,
v/v; 1 mg/ml ovalbumin), three times in low-salt
buffer (50mM Tris-HC1, pH 8.0; 5 mM EDTA;
150mM NaC1; and 0.5% Triton-X-100) and boiled
4 min in Laemmli sample buffer (Laemmli, 1970).
Both reduced and nonreduced samples were run
on 5-15% NaDodSO4 polyacrylamide gels.
Affinity Purification
A BioRad Affi-gel Protein A MAPS kit was used
according to manufacturer’s instructions. Eluted
fractions were dialyzed against APBS and ana-
lyzed for protein content using the spectrophoto-
metric method of Groves et al. (1968).
Tissue Culture
Embryonic mesoderm. Stage 20 embryos were
placed in sterile 100% DeBoer’s solution (DBS,
0.11 M NaC1, 1.3 mM KC1, 4mM CaC12, pH 7.2,
with NaHCO3) containing 1% pen-strep
(10,000 U/ml-10 mg/ml). Jelly coats and vitelline
membranes were .removed using watchmaker’s
forceps. Embryos were passed through ten
changes of 10% DBS containing 1% pen-strep.
Lateral plate mesoderm was removed from 20-
hr-old embryos and transferred to 96 well microt-
iter plates containing dilute L-15 media (200
milliosmole) supplemented with 1.25x10
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NaHCO3, Fe-Transferrin (28/g/ml), 5x10
-5M 2-
ME, and 1% pen-strep, and gassed with 5% CO2
in air. Explants were cultured for periods ranging
from 1 to 10 days as previously described
(Turpen and Smith, 1985).
Metabolic activation. The MTT (3-[4,5-
Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) assay described by Mossman (1983)
was modified for use in a solid-phase assay with
amphibian cells. Complete details of the develop-
ment of this protocol will be published else-
where. Briefly, goat antirnouse IgG (10/tg/ml)
(TAGO, Inc.) was immobilized onto 96 well flat
bottom microtiter plates (Falcon) according to
Wysocki and Sato (1978). After blocking the
plates with 5% BSA, varying concentrations of
test antibodies (CL21, 76-2-11, XT2.1) were added
and incubated 2-4 hr at 4C. Splenocytes, 1-2x105
per well, were plated in RPMI 1640 with NaHCO3
(diluted to 220 milliosmoles) and containing
10mM Hepes, 1% pen-strep Glutamine (Irvine
Scientific), 1 mM Sodium Pyruvate, 5x10-5M
2ME, 28/tg/ml Fe-Transferrin (Sigma, Human
Transferrin), 120tg/ml delipidated, deionized
BSA, and 2 nM phorbal-myristate acetate. Con-
centrations of Con-A ranged from 0 to 10/g/ml.
Final culture volume was 100/1. per well. Cul-
tures were maintained at 26C in 5% CO2 in air.
After 48 hr, 10/1 of MTT (5 mg/ml in APBS) was
added to each well: At 72 hr, the assay was devel-
oped by adding 200/tl of acidified (0.04N HC1)
isopropanol and incubating at room temperature
for 30 to 60 min or until all crystals were dis-
solved. The assay was read on a Skatron Eliza’
Reader with a reference wavelength of 620 nm
and a test wavelength of 570nm. Data are
expressed as change in optical density calculated
by subtracting unstimulated from stimulated
optical-density values.
Immunofluorescence
Cytology. Cell suspensions from embryos
and mesodermal cultures as well as larval and
adult hematopoietic organs were collected with a
cytocentrifuge (Shandon Southern), air dried
3min, fixed in 70% EtOH in DBS at 4C for
5 min, postfixed in 95% EtOH for 2 min, and
stored in a dessicator. Prior to antibody staining,
slides were rehydrated with APBS containing
0.5% BSA and incubated overnight at 4C with
either 50/1 or a 1:50 dilution of ascites or 100
of tissue culture supernatant. Slides were washed
three times in APBS, incubated for 1 hr with
FITC-labeled goat antimouse IgG Fab2’ (20/
g/ml) (TAGO, Inc.), washed three times, and
mounted in 10% glycerol in APBS. Stained prep-
arations were examined using epifluorescence
and a Zeiss IM 30 inverted microscope equipped
with a 50-W mercury light source.
Histology. Adult tissue was snap frozen by
embedding in Tissue Tek O.T.C. compound
(Baxter Scientific) followed by immersion in an
isopentane bath containing dry ice. Specimens
were stored at-70C prior to sectioning. Ten
micron sections were cut with a cryostat, fixed in
acetone, and stained as before.
Flow cytometry. For cell-surface immuno-
fluorescence, 105 live cells were incubated 45 min
with 100/tl culture supernatant, 1/100 dilution of
ascites or 20/g/ml affinity-purified antibody,
washed twice at 4C in APBS containing 0.5%
BSA plus 0.5% sodium azide (ABA), incubated
for 30 min in FITC-labeled goat antimouse IgG
Fab2’ (20/g/ml) washed twice, and analyzed
using a Ortho 50 H flow cytometer equipped
with an argon laser, set at 488 nm with an output
of 150mW. Data were collected and analyzed
using Cicero (Cytomation Inc., Boulder, CO).
For cell sorting, 10 splenocytes were incubated
in 100 tl ABAcontaining 20/g/ml affinity-puri-
fied antibody and stained as before. CL21 posi-
tive cells were sorted from CL21 negative cells on
the basis of fluorescence intensity using a Becton
Dickinson FACStarplus. The morphology of sorted
cells was examined using cytospin preparations
followed by Giemsa or PAS staining. The PAS
reaction was performed according to Hayhoe and
Quaglino (1988). Briefly, cytospins were fixed
with formalin vapor followed by consecutive
incubations in periodic acid and Schiff’s leucob-
asic fuchsin.
Antibodies
The following antibodies with indicated speci-
ficities were used: mAb XT2.1, anti Xenopus T cell
(Nagata, 1985); mAb XL 1, anti Xenopus leukocyte
(Ohinata et al., 1989); mAb AM20, anti Xenopus
MHC class II (Flajnik et al., 1990); mAb 6.16, anti
Xenopus IgM (Bleicher and Cohen, 1981); mAb
76-2-11, antiswine cytotoxic T cell (Isotype con-LEUKOCYTE ONTOGENY IN XENOPUS 307
trol, ATCC #HB143); unconjugated goat anti-
mouse IgG and FITC-conjugated goat antimouse
IgG F(ab)2’ (TAGO).
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